Jiefeng Cui
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Hepatology top 5%
- Liver physiology and pathology
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Glycosylation and Glycoproteins Research 3
- Ubiquitin and proteasome pathways 3
- Oncology 14
- Cancer Cells and Metastasis 7
- Co-authors
- Rongxin Chen (29 shared papers)Dongmei Gao (27 shared papers)Zhenggang Ren (22 shared papers)Yinying Dong (16 shared papers)Yinkun Liu (23 shared papers)Tong‐Chun Xue (11 shared papers)Qiongdan Zheng (10 shared papers)Xiahui Lin (9 shared papers)
- Journals
- Journal of Experimental & Clinical Cancer Research (4 papers)Journal of Cancer Research and Clinical Oncology (4 papers)PLoS ONE (3 papers)PROTEOMICS (3 papers)Biochemical and Biophysical Research Communications (2 papers)
- Partner nations
- ChinaEthiopiaUnited States
In The Last Decade
Jiefeng Cui
72 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 116
- Cancer Research 531
- Hepatology 218
- Immunology and Allergy 151
- Cell Biology 423
- Oncology 485
Countries citing papers authored by Jiefeng Cui
This map shows the geographic impact of Jiefeng Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiefeng Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiefeng Cui more than expected).
Fields of papers citing papers by Jiefeng Cui
This network shows the impact of papers produced by Jiefeng Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiefeng Cui. The network helps show where Jiefeng Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Jiefeng Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 150 | |
| 2 | 2018 | 116 | |
| 3 | 2022 | 116 | |
| 4 | 2016 | 100 | |
| 5 | 2011 | 95 | |
| 6 | 2013 | 89 | |
| 7 | 2014 | 86 | |
| 8 | 1996 | 81 | |
| 9 | 2022 | 74 | |
| 10 | 2020 | 70 | |
| 11 | 2014 | 68 | |
| 12 | 2020 | 66 | |
| 13 | 2018 | 54 | |
| 14 | 2016 | 48 | |
| 15 | 2005 | 46 | |
| 16 | 2020 | 43 | |
| 17 | 2017 | 42 | |
| 18 | 2006 | 42 | |
| 19 | 2015 | 42 | |
| 20 | 2021 | 41 |
About Jiefeng Cui
Jiefeng Cui is a scholar working on Molecular Biology, Oncology, Cell Biology, Cancer Research and Rheumatology, having authored 75 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (7 papers), Cellular Mechanics and Interactions (7 papers), Cancer, Hypoxia, and Metabolism (7 papers), Cell Adhesion Molecules Research (5 papers), Glycosylation and Glycoproteins Research (3 papers), Ubiquitin and proteasome pathways (3 papers), Bone and Dental Protein Studies (3 papers) and Liver physiology and pathology (3 papers). The work is most often cited by research in Cancer Research (531 citations), Hepatology (218 citations), Immunology and Allergy (151 citations), Cell Biology (423 citations) and Oncology (485 citations). Jiefeng Cui has collaborated with scholars based in China, Ethiopia and United States. Frequent co-authors include Rongxin Chen, Dongmei Gao, Zhenggang Ren, Yinying Dong, Yinkun Liu, Tong‐Chun Xue, Qiongdan Zheng, Xiahui Lin, Yang You and Sifan Wu. Their work appears in journals such as Journal of Experimental & Clinical Cancer Research, Journal of Cancer Research and Clinical Oncology, PLoS ONE, PROTEOMICS and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.